Current Ratio of 4D Molecular Therapeutics, Inc. from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
4D Molecular Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • 4D Molecular Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 1082%, a 52% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

4D Molecular Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 1082% -1169% -52% 30 Sep 2025
Q2 2025 1316% -1033% -44% 30 Jun 2025
Q1 2025 1745% -452% -21% 31 Mar 2025
Q4 2024 2154% +304% +16% 31 Dec 2024
Q3 2024 2251% +429% +24% 30 Sep 2024
Q2 2024 2349% +549% +31% 30 Jun 2024
Q1 2024 2198% +546% +33% 31 Mar 2024
Q4 2023 1850% +158% +9.4% 31 Dec 2023
Q3 2023 1822% +85% +4.9% 30 Sep 2023
Q2 2023 1800% +116% +6.9% 30 Jun 2023
Q1 2023 1651% -189% -10% 31 Mar 2023
Q4 2022 1692% -124% -6.9% 31 Dec 2022
Q3 2022 1737% -116% -6.2% 30 Sep 2022
Q2 2022 1684% 30 Jun 2022
Q1 2022 1840% 31 Mar 2022
Q4 2021 1816% 31 Dec 2021
Q3 2021 1853% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.